RED BANK, N.J., Jan. 6, 2021 /PRNewswire/ -- Provention Bio,
Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to
intercepting and preventing immune-mediated disease, today
announced that management will participate in a fireside chat
presentation at the H.C. Wainwright BioConnect 2021 Conference,
being held virtually January 11-14,
2021.
A replay of the pre-recorded fireside chat will be available
beginning Monday, January 11, at
6:00 am E.T. and can be accessed by
visiting the Events and Webcasts section of the Company's
website: http://investors.proventionbio.com/events. The
webcast will be archived on the Company's website for 30 days
following the presentation.
About Provention Bio, Inc.:
Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical
company focused on advancing the development of investigational
therapies that may intercept and prevent debilitating and
life-threatening immune-mediated disease. The Company has submitted
a Biologics License Application (BLA) to the FDA for its lead
investigational drug candidate, teplizumab, for the delay or
prevention of clinical type 1 diabetes in at-risk individuals. The
Company's pipeline includes additional clinical-stage product
candidates that have demonstrated in pre-clinical or clinical
studies proof-of-mechanism and/or proof-of-concept in other
autoimmune diseases, including celiac disease and lupus. Visit
www.ProventionBio.com for more information and follow us on
Twitter: @ProventionBio.
Internet Posting of Information:
Provention Bio, Inc. uses its
website, www.proventionbio.com, as a means of disclosing
material nonpublic information and for complying with its
disclosure obligations under Regulation FD. Such disclosures will
be included on the Company's website in the "News" section.
Accordingly, investors should monitor this portion of the Company's
website, in addition to following its press
releases, SEC filings and public conference calls and
webcasts.
Investor Contact:
Sam
Martin, Argot Partners
sam@argotpartners.com
212-600-1902
Media Contact:
Lori
Rosen, LDR Communications
lori@ldrcommunications.com
917-553-6808
View original content to download
multimedia:http://www.prnewswire.com/news-releases/provention-bio-to-participate-in-the-hc-wainwright-virtual-bioconnect-conference-301202297.html
SOURCE Provention Bio, Inc.